Regeneron Securities Fraud Lawsuit, Were You Affected? — Cheatham v. Regeneron Pharmaceuticals, Inc., No. 7:26-cv-06026
September 14, 2026. That’s the deadline to ask a federal court to lead the Regeneron securities fraud case, not to file a claim, since none exists yet. Investors who bought REGN stock between August 1, 2025 and May 15, 2026 say the company downplayed real risk in its cancer drug trial before the truth came…
